Drug Shortage Report for LASIX SPECIAL
Report ID | 172122 |
Drug Identification Number | 02224755 |
Brand name | LASIX SPECIAL |
Common or Proper name | LASIX SPECIAL |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | FUROSEMIDE |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | Bottle of 20 tablets |
ATC code | C03CA |
ATC description | HIGH-CEILING DIURETICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-10-21 |
Actual start date | 2022-10-25 |
Estimated end date | 2023-01-31 |
Actual end date | 2023-01-18 |
Shortage status | Resolved |
Updated date | 2023-01-19 |
Company comments | Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2023-01-19 | French | Compare |
v10 | 2023-01-19 | English | Compare |
v9 | 2023-01-06 | French | Compare |
v8 | 2023-01-06 | English | Compare |
v7 | 2022-11-17 | French | Compare |
v6 | 2022-11-17 | English | Compare |
v5 | 2022-10-28 | French | Compare |
v4 | 2022-10-28 | English | Compare |
v3 | 2022-10-22 | English | Compare |
v2 | 2022-10-19 | French | Compare |
v1 | 2022-10-19 | English | Compare |
Showing 1 to 11 of 11